Bud Genius in Stock Buyback Talks

3
Sep

The Board of Directors of Rightsmile Inc., which is soon to be called Bud Genius Inc. (Symbol: RIGH), yesterday declared that it is in talks regarding a buyback of its common stock.

The decision was influenced by company expansion by its new subsidiary, Genius Biotech Corporation, which may be listed on the OTC:BB complete with a registration.

Company CEO, Angel Stanz, provided the following quote: “The number of outstanding shares needs to be reduced. All stock buybacks will be followed by a corresponding reduction in the number of authorized shares as well. We felt it would be cheaper to do this now, before our new subsidiary has grown. We have disclosed that we are considering an OTC:BB listing for the company, so this is an opportune time for us to concentrate shareholder value. By now I have my eye on a few pieces of stock that I would like to reclaim. Any buybacks may vary in size, and we can’t negotiate everything at once, but that’s okay because it can really pay off in the long run. By doing this, we are putting our money where our mouth is, because we are in this for the long-term growth.”

About Bud Genius

An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories. Certification, data collection, and online reports are the measure by which the company gains.

For more information please visit: http://www.BudGenius.com

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management’s expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contacts
Bud Genius
Angel Stanz, 855-723-3283
Chief Executive Officer
PR@BudGenius.com